2023 Form 5500 filing — Fate Therapeutics, Inc. 401(K) Pension Plan

Plain-English filing summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20241001133220NAL0003316915001) for Fate Therapeutics, Inc. 401(K) Pension Plan, reported by Fate Therapeutics, Inc. under EIN 65-1311552 and plan number 001. It reports 652 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).

EFAST2 acknowledgement
20241001133220NAL0003316915001
Filing year
2023
Form type
2
Plan sponsor
Fate Therapeutics, Inc.
EIN
65-1311552
Plan number
001
Location
San Diego, CA
Participants
652
Schedules available
Schedule H, Schedule C
Received date
not reported in the loaded dataset

Reported financial snapshot (2023)

Total assets (EOY)
$28,482,322
Total liabilities (EOY)
$0
Net assets (EOY)
$28,482,322
Employer contributions
$1,851,853
Participant contributions
$4,396,408
Total income / additions
$11,152,725
Benefits paid
$5,812,620
Administrative expenses
$135,592
Total expenses
$5,954,053
Net increase / (decrease)
$5,198,672
Schedule source
Schedule H

Reported service provider compensation (Schedule C)

Compensation reported on the 2023 filing
ProviderServiceDirect comp.Indirect comp.
Fidelity Investments InstitutionalRECORDKEEPER$70,768$0
Mma SecuritiesADVISOR$64,824not reported in the loaded dataset

Related Form 5500 pages